Anatol M.
- Country
- Poland
- Department
- Neurology
Research Overview
- Efficacy and Safety of Vormatrigine in Adults with Focal Epilepsy Receiving Concomitant Antiseizure Medications: A Randomized, Double-Blind, Placebo-Controlled Trial
- Efficacy and Safety Evaluation of PRAX-628 in Adults with Focal Epilepsy: A Double-Blind, Randomized, Multicenter Trial
- Evaluation of Donanemab, Florbetapir (18F), and Flortaucipir (18F) in Early Symptomatic Alzheimer's Disease: A Randomized, Double-Blind, Placebo-Controlled Trial
Data & Insights
Has run more than one trial at 38 of 118 partner sites.
Specializations
Inflammatory and autoimmune disease
Clinical research activity includes rheumatoid arthritis, psoriatic arthritis, axial spondyloarthritis, systemic lupus erythematosus, and Sjögren’s syndrome, with additional involvement in diffuse cutaneous systemic sclerosis and other rheumatologic disease areas.
- Rheumatoid arthritis
- Psoriatic arthritis
- Systemic lupus erythematosus
- Sjögren’s syndrome
Research interests also extend to chronic spontaneous urticaria, atopic dermatitis, prurigo nodularis, and vitiligo, reflecting a broad therapeutic focus in immune-mediated skin and joint disorders.
Neurology and pain disorders
The investigator is involved in studies of migraine, including chronic migraine, episodic migraine, and menstrual migraine, as well as focal epilepsy, trigeminal neuralgia, and motor fluctuations in advanced Parkinson’s disease.
- Chronic migraine
- Focal epilepsy
- Trigeminal neuralgia
- Parkinson’s disease
Additional activity includes chronic non-specific low back pain and post-surgical neuropathic pain, indicating a strong interest in persistent pain syndromes and neurologic symptom control.
Cardiometabolic and vascular medicine
Research involvement covers atherosclerotic cardiovascular disease, acute coronary syndrome, atrial fibrillation, heart failure, hypertension, and dyslipidemia, with a particular emphasis on hypertriglyceridemia and elevated lipoprotein(a).
- Atherosclerotic cardiovascular disease
- Atrial fibrillation
- Heart failure
- Hypertriglyceridemia
Further interests include obesity, type 2 diabetes mellitus, chronic kidney disease, and prevention of major adverse cardiovascular events, supporting a broad cardiometabolic research portfolio.
Gastroenterology and hepatology
Clinical trial activity includes Crohn’s disease, ulcerative colitis, celiac disease, primary biliary cholangitis, and gastroesophageal reflux disease, together with erosive esophagitis and cancer-associated cachexia.
- Crohn’s disease
- Ulcerative colitis
- Primary biliary cholangitis
- Metabolic dysfunction-associated steatohepatitis
Research interests also span non-alcoholic steatohepatitis, metabolic dysfunction-associated steatotic liver disease, and fibrosis, highlighting involvement in inflammatory bowel and liver disease therapeutics.
Respiratory, metabolic, and musculoskeletal conditions
The investigator also participates in studies of chronic obstructive pulmonary disease, respiratory syncytial virus infection, obesity, knee osteoarthritis, and osteoporosis, with additional work in gout with hyperuricemia and insomnia disorder.
- Chronic obstructive pulmonary disease
- Respiratory syncytial virus infection
- Osteoporosis
- Gout with hyperuricemia
Other areas include weight management, metabolic disease, and neuromuscular pain, reflecting engagement across chronic respiratory, skeletal, and metabolic therapeutic domains.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.